The growing scale of dementia in the UK

September 21, 2017 by Al Mccartney

To mark World Alzheimer's Day Imperial's head of brain sciences describes some of the research being done at the College into the condition.

Alzheimer's disease is the most common form of , a collection of symptoms associated with a decline in brain function, including memory loss, impaired judgment, language and becoming generally less 'sharp' mentally.

World Alzheimer's Day is an annual opportunity for organisations to raise awareness of the condition and the growing number of people affected by it.

More than 225,000 people are expected to be diagnosed with some form of dementia in the UK this year alone, and the number is set to grow with the UK's ageing population.

Alzheimer's is thought to account for 62 per cent of dementia diagnoses, and is a progressive condition chiefly affecting older adults over 80. However, the symptoms can also arise in those under 80, with cases of early onset affecting working age adults, chipping away at memory and cognition.

Professor Paul Matthews, Edmond and Lily Safra Chair and Head of Brain Sciences at Imperial College London explains that Alzheimer's disease involves the "triggering of abnormal protein production in the brain".

Two of these proteins, beta-amyloid and tau, form the characteristic clumps and tangles seen in the brains of patients with Alzheimer's thought to damage the neurons, causing the nerve cells to progressively decline and leading to changes in cognition and behaviour.

Credit: Imperial College London

A growing problem

Commenting on the current scale of the problem, Professor Matthews said: "Dementia is a growing and major problem in the United Kingdom, as it is in all developed nations.

"Currently, there are about 900,000 people with one form of dementia or another, and roughly one in 14 people over the age of 65 will develop dementia.

"Because our population is ageing over time, the number of people in the UK with dementia will grow. By 2025, there could be as many as two million people."

Imperial is one of a number of institutions in the UK pooling expertise as part of the Dementia Research Institute (DRI), a network of academic centres of excellence across the UK working towards common research goals to better understand dementia.

Earlier this year, the College was chosen as one of several satellite centres for the UK DRI, to harness the expertise from multiple fields and to explore the factors contributing to dementia.

Imperial's role in dementia research

Funded by the Medical Research Council, Alzheimer's Society and Alzheimer's Research UK, the UK DRI is based at University College London, with satellite centres in Edinburgh, Cardiff, Cambridge and London – including Imperial College London and Kings College London.

Professor Matthews, Associate Director of the UK DRI, said: "Imperial College has been asked to play a key role in the UK DRI. All of the centres are working together towards common broad scientific objectives.

"But Imperial will take the lead in developing novel neuro-technologies, exploring the way the metabolome and microbiome – the many bugs in our gut – work to modulate the brain and the brain's immune system, and understand the role that sleep plays both in controlling inflammation in the , and the abnormal proteins associated with Alzheimer's Disease."

Explore further: Online dementia publication sheds light on latest research

Related Stories

Online dementia publication sheds light on latest research

September 21, 2017
More than 400,000 Australians live with dementia and that number is expected to climb to 1.1 million by 2056.

Deaths from Alzheimer's disease in Scotland increase by 33.4% in one year

September 14, 2017
Deaths from Alzheimer's in Scotland have soared by 33.4 percent in a year, according to new statistics released by the National Records of Scotland today.

Lack of REM sleep may lead to higher risk for dementia

August 23, 2017
Spending less time in REM (rapid eye movement) sleep and taking longer to enter REM sleep are separately associated with a higher risk of developing dementia.

Hearing loss linked to early memory and thinking problems

July 17, 2017
Researchers at the Alzheimer's Association International Conference 2017 have suggested that people with a family history of Alzheimer's disease who experience hearing loss, are more likely to also experience a decline in ...

Research shortfall on common form of dementia highlighted

July 11, 2017
New research published in The Lancet has highlighted the scarcity of evidence on the prognosis of dementia with Lewy bodies, the second most common cause of degenerative dementia, which affects 100,000 people in the U.K.

Alzheimer's disease patients with psychosis more likely to be misdiagnosed, study suggests

June 30, 2017
People with Alzheimer's disease who experience psychosis—including delusions and hallucinations—are five times more likely to be misdiagnosed with dementia with Lewy bodies compared to patients who do not, new research ...

Recommended for you

Canola oil linked to worsened memory and learning ability in Alzheimer's

December 7, 2017
Canola oil is one of the most widely consumed vegetable oils in the world, yet surprisingly little is known about its effects on health. Now, a new study published online December 7 in the journal Scientific Reports by researchers ...

Genetics study suggests that education reduces risk of Alzheimer's disease

December 7, 2017
The theory that education protects against Alzheimer's disease has been given further weight by new research from the University of Cambridge, funded by the European Union. The study is published today in the BMJ.

Healthy mitochondria could stop Alzheimer's

December 6, 2017
Alzheimer's disease is the most common form of dementia and neurodegeneration worldwide. A major hallmark of the disease is the accumulation of toxic plaques in the brain, formed by the abnormal aggregation of a protein called ...

Alzheimer's damage in mice reduced with compound that targets APOE gene

December 6, 2017
People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease.

Lithium in water associated with slower rate of Alzheimer's disease deaths

December 5, 2017
Rates of diabetes and obesity, which are important risk factors for Alzheimer's disease, also decrease if there is a particular amount of lithium in the water, says the study, published recently in the Journal of Alzheimer's ...

Hyperbaric oxygen therapy may alleviate symptoms of Alzheimer's Disease

December 5, 2017
A new Tel Aviv University study reveals that hyperbaric oxygen treatments may ameliorate symptoms experienced by patients with Alzheimer's disease.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.